CLINICAL SCIENCES Evolution of Hematopoietic Stem Cell Transplantation in Eastern andWestern Europe from 1990 to 2003. A Report from the EBMT Activity Survey
نویسندگان
چکیده
Transplantation of hematopoietic stem cells (HSCT) has seen rapid expansion during the last decade. It is evident that there are differences between eastern andwestern European countries when this high cost procedure is concerned. In order to obtain more insight into the mechanisms associated with these differences, we compared the transplant rates (number of transplants per 10 million population) for allogeneic and autologous HSCT between selected eastern and western European countries and looked for factors associatedwith their differences. Datawere obtained by the annual European Group for Blood and Marrow Transplantation (EBMT) activity survey for the period from 1990 to 2003. Transplant rates were substantially lower in eastern European countries for autologous, allogeneic, and unrelated HSCT throughout the observation period. The rapid increase in transplant rates during the 1990s occurred later in eastern European countries. Transplant rates continued to rise during the last three years in eastern European countries in contrast to aplateau in transplant rates inwesternEuropeancountries. Therewas a clear correlationbetweeneconomic factors, measured as gross national income per capita, and transplant rates for low-income countries. Therewas also a clear correlation between team density (number of teams per 10 million population) and transplant rates. These data document that economic factors explain the differences in transplant rates between eastern and western European countries only in part. Another important factor seems to be the access to the therapeutic procedure. These data provide a basis for health care planning.
منابع مشابه
Pediatric Hematopoietic Stem Cell Transplantation
The introduction and evolution of hematopoietic stem cell transplantation (HSCT) could be traced back to 1950s, to the studies on interactions among irradiation, covering spleen and bone marrow from it and injection of bone marrow cells. Today, HSCT is considered a well-established, effective and promising means of therapy for various malignant and non-malignant medical conditions, both in chil...
متن کاملAssociation between CRP Level on Admission Day and Length of Hospitalization and Engraftment in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
Background and purpose: Several studies investigated the role of C-reactive protein (CRP) during transplantation and inflammation, and clinical outcomes after stem cell transplantation. In this study, we examined the relationship between the earliest CRP level on admission day, and the first outcome after transplantation, myeloid and platelet engraftment, and the length of hospitalization in p...
متن کاملFeasibility of high-dose iodine-131-metaiodobenzylguanidine therapy for high-risk neuroblastoma preceding myeloablative chemotherapy and hematopoietic stem cell transplantation: a study protocol
Objective(s): High-risk neuroblastoma is a childhood cancer with poorprognosis despite modern multimodality therapy. Internal radiotherapy using131I-metaiodobenzylguanidine (MIBG) is effective for treating the disease even if it isresistant to chemotherapy. The aim of this study is to evaluate the safety and efficacyof 131I-MIBG radiotherapy combined with myeloablative high-dose chemotherapyand...
متن کاملA 16 Month Survey of Cyclosporine Utilization Evaluation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Objectives: Graft versus host disease (GVHD) is a life threatening reaction in the stem cell transplantation process. Nowadays Cyclosporine is the most commonly utilized agent for GVHD prophylaxis and it has a major role in successful transplantation. Cyclosporine has been applied for many years in this field but it could be stated that currently no general consensus is available for its optima...
متن کاملA 16 Month Survey of Cyclosporine Utilization Evaluation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Objectives: Graft versus host disease (GVHD) is a life threatening reaction in the stem cell transplantation process. Nowadays Cyclosporine is the most commonly utilized agent for GVHD prophylaxis and it has a major role in successful transplantation. Cyclosporine has been applied for many years in this field but it could be stated that currently no general consensus is available for its optima...
متن کامل